Challenges and recent advances in erythropoietin stability
Bahgat Fayed1, Shanshan Luo2, Alaa Eldeen B Yassin3,4
1Department of Chemistry of Natural and Microbial Products, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Giza, Egypt.
Pharmaceutical Development and Technology
|September 28, 2024
Summary
Erythropoietin (EPO) stability is crucial for its therapeutic effectiveness in treating anemia. Research explores strategies to enhance EPO stability, improving drug development and patient outcomes.
Area of Science:
- Biochemistry
- Pharmacology
- Biotechnology
Background:
- Erythropoietin (EPO) regulates red blood cell production, with recombinant human EPO (rh-EPO) improving anemia treatment since 1989.
- EPO is synthesized mainly by the kidneys and liver.
- rh-EPO is widely used for anemia in chronic kidney disease, cancer, and other conditions.
Purpose of the Study:
- To review the critical role of EPO stability in maintaining biological activity and therapeutic efficacy.
- To examine the impact of EPO instability on drug development and clinical outcomes.
- To comprehensively survey current strategies for stabilizing EPO.
Main Methods:
- Literature review of EPO stability, instability factors, and stabilization techniques.
- Analysis of the effects of environmental conditions (temperature, light) on EPO.
- Evaluation of formulation strategies including stabilizing agents, lyophilization, and novel delivery systems.
Main Results:
- EPO instability, characterized by degradation and loss of activity, poses challenges to therapeutic efficacy.
- Temperature fluctuations, light exposure, and substance interactions contribute to EPO instability.
- Various strategies, including excipients, lyophilization, and advanced formulations, are being developed to enhance EPO stability.
Conclusions:
- Ensuring EPO stability is paramount for successful anemia treatment and effective drug development.
- Innovative stabilization strategies are essential to overcome the limitations posed by EPO's inherent instability.
- Continued research into EPO stabilization will improve therapeutic outcomes for patients with anemia.
Related Concept Videos
01:14Erythropoiesis
4.1K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.1K
01:26Protein Modifications in the RER
5.1K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
5.1K
01:53RNA Stability
33.3K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.3K
02:51mRNA Stability and Gene Expression
5.5K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
5.5K
01:22Lifecycle of Erythrocytes
1.9K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
1.9K
01:29Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K